Flt-4 Antibodies

Santa Cruz Biotechnology provides a broad selection of Flt-4 monoclonal antibodies for research focused on understanding Flt-4 protein functions. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Flt-4, also known as vascular endothelial growth factor receptor 3 (VEGFR-3), plays a critical role in lymphangiogenesis and the development of the lymphatic system. The protein is essential for the regulation of fluid homeostasis and immune responses, making it a significant target in cancer research and therapeutic development. Understanding Flt-4 function can provide insights into various pathological conditions, including tumor progression and metastasis. Researchers can utilize Flt-4 monoclonal antibodies to investigate lymphatic vessel formation and development. The high specificity of Flt-4 monoclonal antibodies enables precise detection and analysis of VEGFR-3 expression patterns in different tissue types. Additionally, Flt-4 monoclonal antibodies support studies examining the relationship between lymphatic vessels and immune cell trafficking. Santa Cruz Biotechnology monoclonal antibodies for Flt-4 research contribute to advancing our understanding of lymphatic system development and its role in health and disease.